not tagged
not tagged
[]
beautiful trial presented by : biomarker-driven 1l treatment in high-risk
lbcl (nlg-lbc-06) r-da-epoch-r may overcome the adverse impact of biological risk factors, apart from tp53 alterations &amp; ctdna burden eot ctdna mrd predicts os and complements pet #17icml 
MD at @USAL | Internal Med student at @HematoCAUSA | #cytopath #cytometry and #lymphoma at Hospital Ramón y Cajal @HematoRYC | PhD student at @UAHes